Astro Pak launches decontamination services subsidiary
Astro Pak Corporation, a US precision cleaning company, has launched a subsidiary, SixLog, to provide on-site biological decontamination services using proprietary iHP (ionised hydrogen peroxide) technology to the life sciences, pharmaceutical and healthcare industries.
SixLog, headquartered in Santa Ana, California, performs decontamination services for equipment, rooms, entire buildings and modes of transport such as ambulances, trains and cruise ships.
The iHP bio decontamination technology was developed for military applications and this will be the first time that it will be used in commercial applications.
The company says technology can be used in open air and, once ionised, it acts like a gas as opposed to a vapour, providing excellent distribution properties and destroying micro-organisms even in hard-to-reach areas.
Steve Feinstein, formerly regional sales manager of a UK manufacturer of hydrogen peroxide vapour generators, has been appointed as SixLog's director of technology.
In addition to the company launch, SixLog has developed a website containing technical papers, presentations, and other downloads on biological decontamination and sterilisation.
You may also like
Manufacturing
Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies
Read moreNew platform leverages the established Curator platform methodology to industrialise Lentivirus processes from concept to clinic
Trending Articles
You may also like
Manufacturing
Bora Group to acquire MacroGenics’ manufacturing operations and CDMO business
The purchase will hand the Group a biologics drug substance manufacturing facility and a warehousing centre in Maryland, which Bora plans to use in cooperation with Tanvex Biopharma to scale its end-to-end biologics platform
Finance
Cambridge biotech Verinnogen secures £500k CPI investment to advance cancer drug development
The investment will advance a handheld device delivering more precise and reproducible tumour size measurements in preclinical oncology research, addressing variability in existing techniques that can slow drug development and necessitate costly repeat studies
Manufacturing
Adragos Pharma appoints Kostas Rengis as Chief Executive Officer
Munich, Germany – May 7th, 2026 – Adragos Pharma, a global contract development and manufacturing organisation (CDMO), today announced the appointment of Konstantinos (Kostas) Rengis as its new Chief Executive officer, succeeding Dr. Andreas Raabe, who founded the company and has led it over the past six years
Research & Development
Syngene strengthens leadership team with two key appointments to support next phase of growth
Abhijit Zutshi joins as CCO and Maninder Kapoor Puri as CHRO. India/U.S./UK, 1 May 2026: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the Abhijit Zutshi as Chief Commercial Officer (CCO) and Maninder Kapoor Puri as Chief Human Resources Officer (CHRO), effective 1 May 2026
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model
Hi Tech Manufacturing
Cirena licenses Agilent long RNA purification technology for high-purity genome editing workflows
Cirena has licensed Agilent Technologies' long RNA purification technology to support scalable production of high-purity 100-300 nt RNA constructs for CRISPR, functional genomics and other advanced research applications